Hospital acquired pneumonia (HAP) is the most frequent hospital acquired infection in England, but little is known about the national burden of the condition. Developing HAP has a pronounced detrimental effect on patient outcomes, increasing length of stay and mortality, and is associated with antimicrobial resistance.
This collaborative project between Liverpool University and the Advancing Quality Alliance (Aqua) investigates the scale of the national HAP burden based on findings from a North West regional initiative, the Advancing Quality (AQ) programme. Eight acute trusts have participated in the AQ HAP programme since October 2020, submitting monthly data on levels of care afforded to HAP patients. The project builds on this successful programme to expand the knowledge base and drive the recognition of HAP as a priority for research and policy.
See HAP Project Phase 1 Report here
In July 2023, we were successful in gaining funding for a further phase of the work, using national data to describe the incidence risk and mortality associated with HAP in England across a five-year period and identifying any regional variation. The report outlining our methodology and findings can be accessed via the link below.
See the HAP Project Phase 2 Report here
Key publications and resources
For more information on this topic, we have a wide range of resources and publications on our HAP literature page.
Aqua’s new Special Advisor: Louise Robson
When it’s time to go, is there anywhere for me to go?
Aqua Programmes are Shortlisted for Two HSJ Awards
NHS England’s Quality Service Improvement and Redesign (QSIR) team transfers to Aqua
New Special Advisors Join Aqua
Action Learning Spaces for CEOs in the East of England
